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Pulmonary surfactant and cardiopulmonary bypass
in infants 
To the Editor:
We read with interest the recent article by Paul and col-
leagues1 describing changes in pulmonary surfactant after
cardiopulmonary bypass (CPB) in a group of infants having
surgery for congenital heart disease.
In this article the authors report concentrations of phos-
pholipid and, indirectly, protein in returned fluid from tra-
cheal lavage. There is no apparent attempt to correct concen-
trations for variable recovery of epithelial lining fluid in these
specimens. To define the concentration of surfactant compo-
nents in sampled secretions, a marker of dilution should be
used, allowing the result to be expressed as concentration in
epithelial lining fluid.2 Results expressed as concentrations in
raw lavage fluid are impossible to interpret meaningfully.
Paul and colleagues do report the phospholipid/protein
ratio of tracheal lavage specimens. This ratio does nothing to
clarify the data and certainly cannot be interpreted as an
attempt to correct for dilution, given their later statement that
alveolar protein concentration is known to be increased after
CPB. A useful marker of dilution of epithelial lining fluid
must not be present in increased concentration in the dam-
aged lung. For this reason protein (along with albumin and
sphingomyelin) is not suitable in this population.3
Paul and colleagues report a significant fall in total phos-
pholipid concentration immediately after CPB. In their dis-
cussion they state: “Our data support the findings of
McGowan and colleagues, who demonstrated an alteration in
surfactant composition in older infants and children after
CPB.” In fact, these findings are at odds with those of
McGowan and colleagues,4 who found no difference in total
phosphatidylcholine recovered by bronchoalveolar lavage
before and after CPB. In the other published study looking at
phospholipid after CPB in children, LeVine and colleagues5
showed no difference in phosphatidylcholine levels between
a group of children who had undergone CPB and a control
group. Both of these studies involved greater numbers of
patients having CPB than in that of Paul and colleagues, and
both are also subject to the same criticism of not appropriately
correcting results for dilution.
There may well be significant abnormalities of pulmonary
surfactant that contribute to postoperative lung dysfunction in
this patient population. McGowan and colleagues4 did find a
change in the proportion of phospholipid in pulmonary sur-
factant subtypes after CPB (a measurement not influenced by
dilution of specimens), which would have important func-
tional implications. This subject warrants further investiga-
tion, but care must be taken to express findings in a way that
will add to our understanding of the consequences of CPB on
the composition and function of pulmonary surfactant.
Kenneth John Millar, MRCP, FRACP
Peter Anderson Dargaville, FRACP
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Reply to the Editor:
We thank Millar and colleagues for their interest in our arti-
cle, “The Role of Cardiopulmonary Bypass and Surfactant in
Pulmonary Decompensation after Surgery for Congenital
Heart Disease.”1 We concur that our data have certain limita-
tions and must be interpreted with a degree of caution.
Although we did not account for the variable recovery of
epithelial lining fluid by using a marker of dilution, we made
every effort to standardize the timing and technique of the
lavage fluid with each procedure. Although a measurement of
dilution may have been helpful, even this method has poten-
tial limitations2 and, as mentioned in the letter, our method is
similar to that used in other studies in children undergoing
bypass for congenital heart disease.3,4 Millar and colleagues
also pointed out the potential limitations to using total protein
as the denominator. However, as stated in our conclusions, we
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believe the decline in the phospholipid/protein ratio seen in
infants receiving bypass is indicative of lung injury. Finally,
by stating that our data support the findings of McGowan and
colleagues,3 we did not mean to imply that we found the same
alteration in surfactant composition that was shown in this
investigation. We were able to demonstrate a quantitative dif-
ference in surfactant, whereas McGowan and associates
showed a qualitative difference, albeit in a different patient
population.
David A. Paul, MD
Jay S. Greenspan, MD
Deborah A. Davis, MD
Pierantonio Russo, MD





R E F E R E N C E S
1. Paul DA, Greenspan JS, Davis DA, Russo P, Antunes MJ. The
role of cardiopulmonary bypass and surfactant in pulmonary
decompensation after surgery for congenital heart disease. J
Thorac Cardiovasc Surg 1999;117:1025-6.
2. NHLBI Workshop Summary. Assessment of lung function and
dysfunction in studies of infants and children. Am Rev Respir Dis
1993;148:1105-8.
3. McGowan FX, Ikegami M, Del Nido PJ, Motoyama EK, Kurland
G, David PJ, et al. Cardiopulmonary bypass significantly reduces
surfactant activity in children. J Thorac Cardiovasc Surg 1993;
106:968-77.
4. Levine AM, Lotze A, Stanley S, Stroud C, O’Donnell R, Whitsett
J, et al. Surfactant content in children with inflammatory lung dis-
ease. Crit Care Med 1996;24:1062-7.
12/8/102475
Complete resection: Yes or no?
To the Editor:
We read with great interest the article titled “Lobe-Specific
Extent of Systematic Lymph Node Dissection for Non–Small
Cell Lung Carcinomas According to a Retrospective Study of
Metastasis and Prognosis” by Asamura and associates (J
Thorac Cardiovasc Surg 1999;117:1102-11). The authors
mentioned that subcarinal lymphadenectomy is not always
necessary for tumors of the right upper lobe and left upper
segment. Their argument is based on the retrospective analy-
sis of their data, which consists of more than 166 cases.
However, we question whether these resections can be classi-
fied as “complete resection.”
The definition of “complete resection” in the management
of non–small cell lung cancer is not uniform in the literature.
The definition provided by Mountain1 has been widely
accepted in the Western world. In this definition, resection
can be considered complete when the highest station sam-
pled at thoracotomy is tumor free and extranodal disease is
not detected in any of the mediastinal nodes. According to
the definition provided by the National Cancer Center in
Japan,2 all the mediastinal stations where tumor can spread
should be removed. Thus more radical node dissection is
required to perform a complete resection according to the
Japanese definition.
Surgical resection can be beneficial only if the resection is
complete. A clearly defined “complete resection” is manda-
tory, not only as a selection criterion for surgery but also for
the postoperative classification of the patients. Otherwise, it
is impossible to detect the positive effect of surgery in the dif-
ferent stages of the disease. We wonder whether Asamura and
associates would consider any resection to be complete with-
out examining all mediastinal nodes.
Asamura and associates argued that subcarinal lymph node
dissection is not necessary for tumors localized to the right
upper lobe and upper division of the left upper segment
because single-station metastases to station 7 are rare. We
wonder how the authors can detect multiple-station metas-
tases, 37% (20/54) of which occur on the right and 50%
(17/34) on the left, without examining all mediastinal sta-
tions. They reported that tumor spread to station 7 was detect-
ed in 12% to 13% of their patients. We think that regardless
of multiple-station or single-station disease, this is too high a
percentage to be neglected. Thus, despite their conclusion,
their data indicate that subcarinal lymphadenectomy should
be performed, which is a relatively easy procedure during
thoracotomy.
A new definition for “complete resection” is urgently need-
ed. We agree with the authors that re-evaluation of the medi-
astinal dissection on the basis of the data collected may be
necessary, but the concept of lung resection for non–small
cell lung cancer should not be changed without the definition
of complete resection being revised. We argue that lung
resection for non–small cell lung cancer without systematic
lymph node dissection should not be performed until a new
definition is provided.
Cemal Asim Kutlu, MD, FETCS
Adnan Sayar, MD
Muzaffer Metin, MD
Yedikule Chest Surgery Center
Istanbul, Turkey
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Reply to the Editor:
We appreciate the interest expressed by Kutlu, Sayar, and
Metin in our consideration of the lobe-specific extent of sys-
tematic lymph node dissection for lung cancer.1 This has been
a point of discussion among thoracic surgeons for a couple of
decades.
Their question can be summarized as follows: Can a pul-
monary resection be regarded as a “complete resection” if
some mediastinal nodes are not examined? Indeed, we have
